Abstract: Disclosed is a compound represented by the Structural Formula (I): 1

Abstract: Disclosed is a compound represented by Structural Formula (I): 1

Abstract: Disclosed is an anti-cancer compound represented by Structural Formula (I): 1

Abstract: Disclosed is a method of preparing a thiohydrazide product compound from a hydrazide starting compound.

Abstract: This invention relates to a water-soluble soybean-based extract including one or more isoflavone glycosides. Also described is a method of preparing such a water-soluble soybean-based extract.

Abstract: One embodiment of the present invention is a compound represented by the Structural Formula (I): 1

Abstract: This invention relates to a water-soluble bean-based extract including one or more isoflavone glycosides. Also included is a method of preparing such a water-soluble bean-based extract.

Abstract: The invention relates to a quinone derivative of the following formula: which is capable of converting into two alkylating agents upon bioreduction. Substituents A, B, C, and D are as described herein.

Abstract: This invention relates to a water-soluble bean-based extract including one or more isoflavone glycosides. Also disclosed is a method of preparing such a water-soluble bean-based extract.

Abstract: This invention relates to a water-soluble soybean-based extract including one or more isoflavone glycosides. Also disclosed is a method of preparing such a water-soluble soybean-based extract.

Abstract: The present invention relates to bis(haloethyl)aminobenzene derivatives featured by having carboxyl-containing moiety and one other moiety at the ortho position with respect to the bis(haloethyl)amino substituent of the benzene ring. The moiety at the ortho position can be alkyl, cycloalkyl, heterocycloalkyl, aryl heteroaryl, alkyl(cycloalkyl), alkyl(heterocycloalkyl), alkyl(heteroaryl), alkyl(aryl), --(--O-alkyl).sub.2-5 or --Y.sup.1 --Y.sup.2 in which Y.sup.1 is O, S, or N(R.sup.5) wherein R.sup.5 is hydrogen or alkyl, and Y.sup.2 is alkyl, alkenyl, cycloalkyl, heterocycloalkyl, aryl, heteroacryl, alkyl(cycloalkyl), alkyl(hetero-cycloalkyl), alkyl(aryl), or alkyl(heteroaryl).

Abstract: A compound which consists of a proactive alkylating moiety containing an electron-withdrawing group, a bioreductive moiety containing at least two double bonds, and a linker joining the proactive alkylating moiety and the bioreductive moiety.

Abstract: A pharmaceutical composition for treatment of cancer in an animal comprising:(A) a therapeutically effective amount of at least one compound selected from the group consisting of compounds represented by the General Formula (I). ##STR1## wherein Z.sub.1 and Z.sub.2, which may be the same or different, each represents an atomic group necessary to form a 5- or 6-membered ring;R.sub.1, R.sub.2 and R.sub.3, which may be the same or different, each represents an alkyl group or an aryl group;L.sub.1 and L.sub.2 each represents a methine group or a substituted methine group;X represents a pharmaceutically acceptable anion;k represents a number necessary for electrical charge balance;n represents 0 or 1; and(B) a pharmaceutically acceptable carrier or diluent.

Abstract: There are provided methine compounds having the following structure and their analogs, with a high solubility and are usefull as an active ingredient for pharmaceutical composition for treatment of cancer: ##STR1##

Abstract: A water-soluble methine compound represented by the following general formula (I): ##STR1## wherein Z.sub.1 and Z.sub.2, which may be the same or different, each represents a non-metallic atomic group required for forming a 5-membered or 6-membered nitrogen-containing heterocyclic ring; R.sub.1 and R.sub.2, which may be the same or different, each represents an alkyl group; Q.sub.1 and Q.sub.2 each represents an atomic group required, in combination, for forming a 4-thiazolidinone ring, a 5-thiazolidinone ring, a 4-imidazolidinone ring, a 4-oxazolidinone ring, a 5-oxazolidinone ring, a 5-imidazolidinone ring or a 4-dithiolanone ring; L.sub.1, L.sub.2, L.sub.3, L.sub.4 and L.sub.5, which may be the same or different, each represents a methine group; R represents a hydrogen atom, an alkyl group, an aryl group or a heterocyclic group; m represents 1 or 2; i and h each represents 0 or 1; l represents 1 or 2; and j and k each represents 0, 1, 2 or 3.

Abstract: A water-soluble methine compound represented by the following general formula (I): ##STR1## wherein Z.sub.1 and Z.sub.2, which may be the same or different, each represents a non-metallic atomic group required for forming a 5-membered or 6-membered nitrogen-containing heterocyclic ring; R.sub.1 and R.sub.2, which may be the same or different, each represents an alkyl group; Q.sub.1 and Q.sub.2 each represents an atomic group required, in combination, for forming a 4-thiazolidinone ring, a 5-thiazolidinone ring, a 4-imidazolidinone ring, a 4-oxazolidinone ring, a 5-oxazolidinone ring, a 5-imidazolidinone ring or a 4-dithiolanone ring; L.sub.1, L.sub.2, L.sub.3, L.sub.4 and L.sub.5, which may be the same or different, each represents a methine group; R represents a hydrogen atom, an alkyl group, an aryl group or a heterocyclic group; m represents 1 or 2; i and h each represents 0 or 1; l represents 1 or 2; and j and k each represents 0, 1, 2 or 3.

Abstract: A novel color image recording method is provided, which comprises exposing to light a light-sensitive material obtained by dispersing a composition containing at least a photopolymerization initiator, a color image-forming substance and a polymerizable compound in a hydrophilic binder and then coating said dispersion on a support, subjecting said polymerizable compound in the exposed portions to polymerization, and then (a) eluting said color image-forming substance contained in the unpolymerized polymerizable compound in the unexposed portions with an alkaline aqueous solution or (b) subjecting said color image-forming substance contained in the unpolymerized polymerizable compound in the unexposed portions to chemical change so that it is discolored, thereby forming dye images.

Abstract: A silver halide photographic material containing a compound having a structure represented by formula (I) ##STR1## wherein EAG represents a group capable of accepting an electron from a reducing material; E represents an electron-attracting group; R.sup.3 represents an atomic group necessary for forming a 5-membered to 8-membered single ring or condensed ring by combining with the carbon atom carrying EAG and E; ETG represents an electron-transmitting group; n represents 0 or 1; R.sup.1 and R.sup.2, which may be the same or different, each represents a hydrogen atom, a hydrocarbon group, a heterocyclic group, or a single bond for forming a ring with EAG; Time represents a group releasing PUG upon cleavage of the bond between the carbon atom carrying R.sup.1 and R.sup.2 and Time; t represents 0 or 1; and PUG represents a photographically useful group.

Abstract: A method for forming an image by silver salt diffusion transfer is described, comprises processing an imagewise exposed photosensitive element provided with a layer of photosensitive silver halide emulsion on a support, and an image-receiving element provided with an image-receiving layer containing a silver-precipitating agent on a support, with an alkali processing composition in the presence of a silver halide solvent, to convert at least part of the unexposed silver halide in the emulsion layer into a transferable silver complex salt, to transfer at least part of said complex salt into the image-receiving layer, and to form an image in the image-receiving layer; the processing being carried out in the presence of at least one compound as described.

Abstract: A silver halide photographic material comprising a support having provided thereon at least one silver halide emulsion layer, wherein the silver halide photographic material contains a compound having discoloration inhibitory activity represented by formula (I):PWR--Time).sub.t MCAP (I)wherein PWR represents a group capable of releasing (Time).sub.t -MCAP upon being reduced; Time represents a group which is released from PWR in the form of (Time).sub.t -MCAP and then releases MCAP through a subsequent reaction; t represents 0 or 1; and MCAP represents a group having discoloration inhibitory activity.